These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27521807)

  • 1. An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder.
    Devine EG; Ryan ML; Falk DE; Fertig JB; Litten RZ
    Contemp Clin Trials; 2016 Sep; 50():178-85. PubMed ID: 27521807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.
    Ryan ML; Falk DE; Fertig JB; Rendenbach-Mueller B; Katz DA; Tracy KA; Strain EC; Dunn KE; Kampman K; Mahoney E; Ciraulo DA; Sickles-Colaneri L; Ait-Daoud N; Johnson BA; Ransom J; Scott C; Koob GF; Litten RZ
    Neuropsychopharmacology; 2017 Apr; 42(5):1012-1023. PubMed ID: 27658483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.
    COMBINE Study Research Group
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
    Zweben A; Piepmeier ME; Fucito L; O'Malley SS
    J Subst Abuse Treat; 2017 Jun; 77():72-78. PubMed ID: 28476276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between physical pain and alcohol treatment outcomes: The mediating role of negative affect.
    Witkiewitz K; McCallion E; Vowles KE; Kirouac M; Frohe T; Maisto SA; Hodgson R; Heather N
    J Consult Clin Psychol; 2015 Dec; 83(6):1044-57. PubMed ID: 26098375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial.
    Zahid R; Dogar O; Mansoor S; Khan A; Kanaan M; Jawad M; Ahluwalia JS; Siddiqi K
    Trials; 2017 Jan; 18(1):14. PubMed ID: 28077163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
    Heffner JL; Tran GQ; Johnson CS; Barrett SW; Blom TJ; Thompson RD; Anthenelli RM
    J Stud Alcohol Drugs; 2010 Jan; 71(1):61-70. PubMed ID: 20105415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
    Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
    J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
    Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
    Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
    Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J
    Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling.
    Toneatto T; Brands B; Selby P
    Am J Addict; 2009; 18(3):219-25. PubMed ID: 19340640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.